Investigating how restrictions on benzodiazepines can prevent overdoses and other health issues
Benzodiazepine restrictions and the prevention of overdoses and other harms
This study looks at how new rules about benzodiazepine prescriptions might affect health, especially in relation to opioid overdoses, and it’s designed to help patients by finding ways to make medication use safer.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10873929 on NIH RePORTER |
What this research studies
This research examines the effects of benzodiazepine restrictions on health outcomes, particularly focusing on their role in opioid-related overdoses and other serious health risks. By analyzing data from TennCare enrollees who experienced changes in benzodiazepine coverage, the study aims to understand the impact of these restrictions on medication use and related harms. The approach involves a natural experiment design, leveraging historical data to assess the consequences of policy changes on patient health. Patients may benefit from insights that could lead to improved prescribing practices and safer medication use.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been prescribed benzodiazepines or are at risk of opioid-related overdoses, particularly those enrolled in Medicaid or Medicare.
Not a fit: Patients who do not use benzodiazepines or are not affected by opioid-related issues may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better guidelines for prescribing benzodiazepines, ultimately reducing overdose risks and improving patient safety.
How similar studies have performed: Previous research has shown that policy changes regarding medication coverage can significantly impact patient outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Wiese, Andrew David — Vanderbilt University Medical Center
- Study coordinator: Wiese, Andrew David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.